IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal of Experimental Therapeutics and Oncology- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

0.20

h-Index

 38

Rank

 17237

SJR

 0.23

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Journal of Experimental Therapeutics and Oncology
Abbreviation J. Exp. Ther. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4)
h-index 38
Overall Rank/Ranking 17237
SCImago Journal Rank (SJR) 0.23
Impact Score 0.20
Publisher Old City Publishing
Country United States
ISSN 13594117, 1533869X




About Journal of Experimental Therapeutics and Oncology


Journal of Experimental Therapeutics and Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4). It is published by Old City Publishing. The overall rank of Journal of Experimental Therapeutics and Oncology is 17237. According to SCImago Journal Rank (SJR), this journal is ranked 0.23. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 38. The best quartile for this journal is Q4.

The ISSN of Journal of Experimental Therapeutics and Oncology journal is 13594117, 1533869X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Experimental Therapeutics and Oncology is cited by a total of 38 articles during the last 3 years (Preceding 2021).


Journal of Experimental Therapeutics and Oncology Impact Score 2021-2022


The impact score (IS) 2021 of Journal of Experimental Therapeutics and Oncology is 0.20, which is computed in 2022 as per its definition. Journal of Experimental Therapeutics and Oncology IS is decreased by a factor of 0.28 and approximate percentage change is -58.33% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Experimental Therapeutics and Oncology Impact Score 2022 Prediction


IS 2021 of Journal of Experimental Therapeutics and Oncology is 0.20. If the same downward trend persists, impact score may fall in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Journal of Experimental Therapeutics and Oncology. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.20
2020 0.48
2019 0.55
2018 0.60
2017 0.44
2016 0.68
2015 0.83
2014 1.62

Journal of Experimental Therapeutics and Oncology h-index


  Table Setting

Journal of Experimental Therapeutics and Oncology has an h-index of 38. It means 38 articles of this journal have more than 38 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Experimental Therapeutics and Oncology ISSN


The ISSN of Journal of Experimental Therapeutics and Oncology is 13594117, 1533869X. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Experimental Therapeutics and Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Experimental Therapeutics and Oncology is 17237. According to SCImago Journal Rank (SJR), this journal is ranked 0.23. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Journal of Experimental Therapeutics and Oncology Publisher


Table Setting

Journal of Experimental Therapeutics and Oncology is published by Old City Publishing. It's publishing house is located in United States. Coverage history of this journal is as following: 1996, 2002-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Experimental Therapeutics and Oncology is J. Exp. Ther. Oncol.. This abbreviation ('J. Exp. Ther. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Experimental Therapeutics and Oncology


If your research field is/are related to Cancer Research (Q4); Drug Discovery (Q4); Pharmacology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Cogent Economics and Finance journal 11814 Taylor and Francis Ltd. 23 1.89
NBER Macroeconomics Annual book series 157 University of Chicago Press 65 1.49
Bilgi Dunyasi journal 20557 University and Research Librarians Association, ankara 4 0.23
Metas de Enfermeria journal 23239 DAE Editorial, Grupo Paradigma 2 0.11
Journal of Organizational Behavior journal 401 John Wiley and Sons Ltd 191 9.23
Archivaria journal 9919 Association of Canadian Archivists 27 0.86
Philological Quarterly journal 23959 University of Iowa 8 0.09
Visions for Sustainability journal 16794 University of Torino 2 1.07
Journal of Marketing Communications journal 4776 Routledge 52 3.59
Clinical Research in Cardiology journal 1551 D. Steinkopff-Verlag 75 5.48

Check complete list




Year wise Impact Score (IS) of Journal of Experimental Therapeutics and Oncology

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.20
2020 0.48
2019 0.55
2018 0.60
2017 0.44
2016 0.68
2015 0.83
2014 1.62



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Cell Chemical Biology
Elsevier Inc. | United States

Protein and Cell
Springer-Verlag GmbH and Co. KG | Germany

Medicinal Research Reviews
John Wiley and Sons Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Emerging Microbes and Infections
Nature Publishing Group | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All